|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||0.33|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Rising interest rates and a looming recession that those higher rates could cause are weighing heavily on stock prices across the board. Shares of Biogen (NASDAQ: BIIB) have been on a roller coaster over the past couple of years. The stock rocketed higher in 2021 after the FDA granted a highly controversial approval to the company's Alzheimer's disease drug, Aduhelm.
Vertex Pharmaceuticals (NASDAQ:VRTX) has had a great run on the share market with its stock up by a significant 11...
Cathie Wood remains optimistic. Her ARK Invest exchange-traded funds (ETFs) have continued to scoop up stocks during the steep downturn this year. But she's apparently not optimistic about all of her ARK holdings.